{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:25:57Z","timestamp":1754144757156,"version":"3.41.2"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cger.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:26:41Z","timestamp":1742228801000},"page":"209-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Voiding Dysfunction and Parkinson Disease in Geriatric Patients"],"prefix":"10.1016","volume":"41","author":[{"given":"Camille P.","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \u201ccommon\u201d neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson\u2019s disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinson Relat Disord"},{"issue":"15","key":"10.1016\/j.cger.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2025.01.006_bib5","first-page":"1310","article-title":"Falls in outpatients with Parkinson\u2019s disease: frequency, impact and identifying factors","volume":"252","author":"Balash","year":"2005","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1742-1241.2009.02326.x","article-title":"The association of nocturia with incident falls in an elderly community-dwelling cohort","volume":"64","author":"Vaughan","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.cger.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-008-0584-4","article-title":"Association of Parkinson\u2019s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study","volume":"19","author":"Fink","year":"2008","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ageing\/afp202","article-title":"Prediction of institutionalization in the elderly. A systematic review","volume":"39","author":"Luppa","year":"2010","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.cger.2025.01.006_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson\u2019s disease: a population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"13","key":"10.1016\/j.cger.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/mds.22089","article-title":"Mutuality of the marital relationship in Parkinson\u2019s disease","volume":"23","author":"Tanji","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.cger.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/mds.21879","article-title":"The evolution of disability in Parkinson disease","volume":"23","author":"Shulman","year":"2008","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.cger.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"issue":"10423","key":"10.1016\/j.cger.2025.01.006_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.0000000000012198","article-title":"2020 Parkinson disease quality measurement set update","volume":"97","author":"Chou","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib15","first-page":"1097","article-title":"The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.cger.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0090-4295(03)00507-7","article-title":"Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson\u2019s disease","volume":"62","author":"Defreitas","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001920050043","article-title":"Is urinary incontinence different in women with Parkinson\u2019s disease?","volume":"10","author":"Myers","year":"1999","journal-title":"Int UrogynEcol J Pelvic Floor Dysfunct"},{"issue":"6","key":"10.1016\/j.cger.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1464-410X.1985.tb07025.x","article-title":"Micturition disturbance in Parkinson\u2019s disease","volume":"57","author":"Fitzmaurice","year":"1985","journal-title":"Brit J Urol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/mds.10403","article-title":"Short-term effect of a single levodopa dose on micturition disturbance in Parkinson\u2019s disease patients with the wearing-off phenomenon","volume":"18","author":"Uchiyama","year":"2003","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.cger.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/brain\/awl302","article-title":"Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson\u2019s disease","volume":"129","author":"Herzog","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/brain\/awm254","article-title":"Improved sensory gating of urinary bladder afferents in Parkinson\u2019s disease following subthalamic stimulation","volume":"131","author":"Herzog","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib23","first-page":"708","article-title":"Brain mechanisms underlying urge incontinence and its response to pelvic floor muscle training","volume":"194","author":"Griffiths","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/nau.22767","article-title":"Abnormal functional connectivity in women with urgency urinary incontinence: can we predict disease presence and severity in individual women using Rs-fcMRI","volume":"35","author":"Nardos","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"18","key":"10.1016\/j.cger.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000260605.12506.86","article-title":"Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease","volume":"68","author":"Brusa","year":"2007","journal-title":"Neurology"},{"issue":"8626\u20138627","key":"10.1016\/j.cger.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(88)90932-4","article-title":"Role of subcutaneous apomorphine in parkinsonian voiding dysfunction","volume":"2","author":"Christmas","year":"1988","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cger.2025.01.006_bib27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.cger.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-144-10-200605160-00005","article-title":"The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence","volume":"144","author":"Brown","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib29","first-page":"1549","article-title":"The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association","volume":"148","author":"Barry","year":"1992","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib30","first-page":"11","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"212","author":"Cameron","year":"2024","journal-title":"J\u00a0Urol"},{"issue":"23","key":"10.1016\/j.cger.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.280.23.1995","article-title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","volume":"280","author":"Burgio","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1464-410X.2012.11736.x","article-title":"Efficacy of adding behavioural treatment or antimuscarinic drug therapy to \u03b1-blocker therapy in men with nocturia","volume":"112","author":"Johnson","year":"2013","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.cger.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1532-5415.2011.03724.x","article-title":"Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial","volume":"59","author":"Burgio","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamainternmed.2019.6398","article-title":"Effectiveness of combined behavioral and drug therapy for overactive bladder symptoms in men: a randomized clinical trial","volume":"180","author":"Burgio","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib35","first-page":"11","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"212","author":"Cameron","year":"2024","journal-title":"J\u00a0Urol"},{"issue":"19","key":"10.1016\/j.cger.2025.01.006_bib36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","article-title":"Behavioral therapy to treat urinary incontinence in Parkinson disease","volume":"76","author":"Vaughan","year":"2011","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.cger.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"e1427","DOI":"10.1212\/WNL.0000000000008931","article-title":"Bladder training for urinary tract symptoms in Parkinson disease: a randomized controlled trial","volume":"94","author":"McDonald","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cger.2025.01.006_bib38","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/nau.24052","article-title":"Behavioral therapy for urinary symptoms in Parkinson\u2019s disease: a randomized clinical trial","volume":"38","author":"Vaughan","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"10.1016\/j.cger.2025.01.006_bib39","article-title":"A\u00a0novel trial of mirabegron and behavioral modification including pelvic floor exercise for overactive bladder in Parkinson\u2019s disease (MAESTRO)","volume":"14","author":"Madan","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.cger.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/nau.20413","article-title":"Randomized clinical trial of efficacy of self-monitoring techniques to treat urinary incontinence in women","volume":"26","author":"Kincade","year":"2007","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"10.1016\/j.cger.2025.01.006_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/aje\/kwr451","article-title":"Caffeine intake, smoking, and risk of Parkinson disease in men and women","volume":"175","author":"Liu","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"17","key":"10.1016\/j.cger.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.1995.03520410060027","article-title":"Predictors of successful prompted voiding among incontinent nursing home residents","volume":"273","author":"Ouslander","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cger.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1532-5415.2001.49146.x","article-title":"Urinary incontinence treatment preferences in long-term care","volume":"49","author":"Johnson","year":"2001","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eururo.2010.11.040","article-title":"Antimuscarinic mechanisms and the overactive detrusor: an update","volume":"59","author":"Andersson","year":"2011","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson\u2019s disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkin Relat Disord"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/21681805.2021.1990994","article-title":"The safety and effectiveness of mirabegron in Parkinson\u2019s disease patients with overactive bladder: a randomized controlled trial","volume":"56","author":"Moussa","year":"2022","journal-title":"Scandinavian journal of urology"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/nau.24552","article-title":"Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson\u2019s disease: a double-blind, randomized placebo-controlled trial (Parkinson\u2019s Disease Overactive bladder Mirabegron, PaDoMi Study)","volume":"40","author":"Cho","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.cger.2025.01.006_bib49","first-page":"333","article-title":"Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications","volume":"108","author":"Fine","year":"2008","journal-title":"JAOA"},{"issue":"25","key":"10.1016\/j.cger.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"Supplement","key":"10.1016\/j.cger.2025.01.006_bib51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00006250-199810001-00045","article-title":"Meta-analysis of estrogen therapy in\u00a0the management of urogenital atrophy in postmenopausal women: second report of\u00a0the Hormones and Urogenital Therapy Committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.cger.2025.01.006_bib52","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.ejca.2005.07.015","article-title":"Vaginal oestrogen therapy after breast cancer: is it safe?","volume":"41","author":"Ponzone","year":"2005","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/nau.20593","article-title":"Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"28","author":"Kabay","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.cger.2025.01.006_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","article-title":"The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"87","author":"Kabay","year":"2016","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.cger.2025.01.006_bib55","first-page":"96.e91","article-title":"Sacral nerve neuromodulation in patients with underlying neurologic disease","volume":"197","author":"Wallace","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.cger.2025.01.006_bib56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons\u2019s disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disorders"},{"issue":"3","key":"10.1016\/j.cger.2025.01.006_bib57","first-page":"960","article-title":"Botulinum toxin type A in patients with Parkinson\u2019s disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.cger.2025.01.006_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"8","author":"Gilman","year":"1998","journal-title":"Clin Auton Res"},{"issue":"5","key":"10.1016\/j.cger.2025.01.006_bib59","first-page":"2209","article-title":"Benign prostatic obstruction and Parkinson\u2019s disease\u2014should transurethral resection of the prostate be avoided?","volume":"181","author":"Roth","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.cger.2025.01.006_bib60","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/mds.20584","article-title":"Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis","volume":"20","author":"Paviour","year":"2005","journal-title":"Mov Disord"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:44:09Z","timestamp":1752623049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069025000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0749069025000060"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.006","relation":{},"ISSN":["0749-0690"],"issn-type":[{"type":"print","value":"0749-0690"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voiding Dysfunction and Parkinson Disease in Geriatric Patients","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}